News

Fuchs endothelial corneal dystrophy (FECD) is a disease of the corneal endothelium, for which surgical management has evolved greatly over recent decades.As part of the Journal Club series between the NYU Grossman School of Medicine Department of Ophthalmology and Ophthalmology Times, participants will discuss recent impactful papers with visiting faculty members across … [Read more...] about Advancing Fuchs dystrophy care: Longterm success of descemet stripping only

A recent study conducted at Helsinki University Hospital, Finland, examined whether diabetes influences anatomical and functional outcomes following epiretinal membrane (ERM) surgery. The findings suggest that the presence of diabetes, glycemic control, or insulin therapy does not significantly affect postoperative outcomes.The study analyzed data from 214 eyes of 214 … [Read more...] about Study: Diabetes does not significantly impact outcomes of epiretinal membrane surgery

Video TranscriptEditor's note –This transcript has been edited for clarity.Rachel Babij, MD, PhD: Hi, I'm Dr. Rachel Babij, one of the residents here at NYU Department of Ophthalmology, and we're here for an installment of NYU Department of Ophthalmology Journal Club, where we will be sitting down with leaders in the field to discuss some of their recent work. Today, I'm here … [Read more...] about NYU Ophthalmology Journal Club: Exploring longterm success of DSO for Fuchs Dystrophy with Deepinder Dhaliwal, MD, LAc

Glaucoma is one of the leading causes of blindness in the world and is commonly known as a “silent thief of sight,” given its deceptive nature. It is characterized as a chronic optic neuropathy, often associated with elevated intraocular pressure (IOP).Though IOP is the only known modifiable risk factor, it is not the sole culprit leading to the damage of retinal ganglion cells … [Read more...] about Exploring electrical stimulation therapy: A promising approach to vision loss in optic neuropathies

Although intravitreal injections are a safe and effective form of drug delivery, the need for frequent injections and the corresponding disruptions to patients’ lives can pose a significant treatment burden for patients. Patients may miss injection visits due to trouble taking time off work or finding someone to bring them to the clinic or because of illness, as many patients … [Read more...] about Advancements in ocular drug delivery

Thyroid eye disease (TED) represents a challenging intersection of autoimmune thyroid dysfunction and ophthalmic complications, often resulting in disfigurement, discomfort, and, in severe cases, vision loss.To explore innovative approaches to treating TED, Ophthalmology Times spoke with Alon Kahana, MD, PhD, of Kahana Oculoplastic & Orbital Surgery in Livonia and Ann … [Read more...] about Targeting IL-6 inflammation: A promising frontier in treating thyroid eye disease

The NYU Grossman School of Medicine Department of Ophthalmology and Ophthalmology Times will host visiting faculty members from all ophthalmologic disciplines and a variety of academic departments in an innovative Journal Club series.Faculty members and our residents will highlight salient findings in recent impactful papers and interpret the methodology, results, and potential … [Read more...] about NYU Grossman School of Medicine launches Journal Club series with expert insights on ophthalmology research